GCF has funded Dr Nuala Helsby and her team at the University of Auckland, a year’s part time salary for a clinical trial manager to support the following research.  THYmine2 is an observational study to assess whether the thymine loading test can prospectively categorise patients who cannot tolerate 5-FU treatment (e.g. FOLFOX, CapeOx, FLOX). This treatment is commonly used in GI and breast cancer treatment. Reactions occur in approximately 10% of patients and can result in life threatening events. Despite extensive research it is still difficult to determine who is at risk of life-threatening toxicity related to 5-FU. This study aims to examine whether the ratio of thymine to its metabolite in urine can discriminate between patients who tolerate 5-FU and those who experience severe 5-FU related toxicity. If successful then it could be a simple and inexpensive way to identify susceptible patients before they start treatment and allow for dose adjustments or alternative treatment. This is partly funded by the David Levene Foundation.

Professor Peter Shepherd, Dr Khanh Tran and their team at the University of Auckland, have been awarded $50,000 for one year to study a form of colorectal cancer which is difficult to treat normally. A drug combination used to treat melonoma will be trialed in the laboratory as a pre-clinical experiment to determine if there is any tumour response using the drugs vemurafenib and axitinib.  This funding is thanks to the Ted and Mollie Carr Fund through Perpetual Guardian. 

 

Subject: Call for Applications: Part time 0.3-0.5 FTE Gastro-Intestinal (GI) Cancer Clinical Research Fellowship

Subject title: GICI NZ: Call for Applications – Part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship

The GI Cancer Institute NZ is calling for applications for:

Part time GI Cancer Clinical Fellowship

The GI Cancer Institute NZ offers one part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship award each year supported by the Hugh Green Foundation. The Fellowship is for the support of outstanding graduates from all relevant health professions, who are able to combine their clinical work with research to improve the quality of life and potential survival for people living with a GI cancer.

The Fellowship is tenable for a period of up to two years. Applications are open to appropriately qualified individuals with New Zealand residency, permanent residency or citizenship, who hold a relevant degree or are in the process of completing their training.

The GI Cancer Clinical Fellowship would be available in (but not limited to) the speciality areas of cancer surgery, radiation oncology, medical oncology, palliative care, cancer genetics, radiology, anatomical pathology, nutrition, psychiatry or public health.

All forms: GICI NZ Call for applications for a GI Cancer Clincal Fellowship 2018 GICI Standard CV Template Please provide all details requested by the 1st March 2018. You will be notified of the outcome of an application by the 1st April 2018.